Molecular epidemiology of hepatitis C virus among injection drug users in Iran: A slight change in prevalence of HCV genotypes over time

Archives of Virology

Volumn 157, Issue 10, 2012, Pages 1959-1965

  Samimi Rad, Katayoun ^a   Nasiri Toosi, Mohsen ^a   Masoudi nejad, Ali ^b   Najafi, Ali ^b   Rahimnia, Ramin ^a   Asgari, Fatemeh ^a   Shabestari, Alireza Namazi ^a   Hassanpour, Gholamreza ^a   Alavian, Seyed Moayed ^c   Asgari, Freshteh ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS;

EID: 84867142749     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1369-9     Document Type: Article

References (26)

1. Rezvan H, Abolghassemi H, Kafiabad SA (2007) Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfusion Med 17: 425-433.
2. Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M (2010) Prevalence of HCV /HIV /HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug policy 21: 493-500.
3. Kheirandish P, Seyed Alinaghi S, Jahani M, Shirzad H, Seyed Ahmadian M, Majidi A, Sharifi A, Hosseini M, Mohraz M, McFarland W (2009) Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. J Urban Health 86: 902-908.
4. Zali MR, Nowroozi A, Amir-rasooly H, Darvishi M (1998) Prevalence of anti HCV antibody and routes of hematological transmission addicts of Ghasr prison [in Persian]. Pajouhesh 22: 26-32.
5. Zamani S, Ichikawa S, Nassiri manesh B, Vazirian M, Ichikawa K, Gouya MM, Afshar P, Ono-Kihara M, Mortazavi Ravari S, Kihara M (2007) Prevalence and correlates of HCV infection among injecting drug users in Tehran. Int J Drug policy 18: 359-363.
6. Mohamad Alizadeh AH, Alavian SM, Jafari K, Yazdi N (2005) Prevalence of HCV infection and its related risk factors in drug abuser prisoners in Hamedan -Iran. World J Gastroenterol 11: 4085-4089.
7. Asgari F, Gooya MM, Mohammad K, Fotouhi A, Yousefi A (2008) Hepatitis C virus infection among Iranian prisoners and its relation with addiction, 2001-2005 [in Persian]. Hakim 11: 1-8.
8. Khani M, Vakili M-M (2003) Prevalence and risk factors of HIV, Hepatitis B virus and Hepatitis C virus infections in Drug addicts among Zanjan prisoners. Arch Iranian Med 6: 1-4.
9. Rowhani Rahbar A, Rooholamini S, Khoshnood K (2004) Prevalence of HIV infection and other blood borne infections in incarcerated and non-incarcerated injection drug users IVDUs in Mashhad. Iran. Int J Drug Policy 15: 151-155.
10. Mohtasham Amiri Z, Rezvani M, Jafari shakib R, Jafari shakib A (2007) Prevalence of HCV infection and risk factors of drug using prisoners in Guilan province. EMHJ 13: 250-256.
11. Micalessi MI, Gerard C, Ameye L, Palasschaert B, Brochier B, Vranckx R (2008) Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. J Med Virol 80: 640-645.
12. Dal Molin G, Ansaldi F, Biagi C, DAgro P, Comar M, Croce L, Tiribelli C, Campello C (2002) Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68: 352-356.
13. Samimi-Rad K, Shahbaz B (2007) Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province. Iran. Haemophilia 13: 156-163.
14. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM (2006) Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran-a multicenter study. J Med Virol 78: 569-573.
15. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, Lankarani KB (2009) Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion 49: 2195-2199.
16. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L (2004) Molecular of epidemiology of Hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol 74: 246-252.
17. Kimura M (1980) A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.
18. Sereno S, Perinelli P, Laghi V (2009) Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started. J Clin Virol 45: 354-357.
19. Kabir A, Alavian SM, Keyvani H (2006) Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 5: 4.
20. Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R (2009) Hepatitis C virus infection among drug injectors in St. Petersburg, Russia: social and molecular epidemiology of an endemic infection. NIH 104: 1881-1890.
21. Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network, Kostrikis LG (2010) Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol 82: 263-270.
22. Abolghassemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, Ehsani MA, Najmabadi H, Akbari MT, Afrasiabi A, Akhavan-Niaki H, Hoorfar H (2007) Thalassemia in Iran: epidemiology, prevention, and management. J Pediat Hematol Onc 29: 233-238.
23. Zali MR, Aghazadeh R, Noroozi A, Amirrasooli H (2001) Anti-HCV antibody among Iranian IV drug users: is it a serious problem? Arch Iranian Med 4: 115-119.
24. Hickman M, Hope V, Brady T, Madden P, Jones S, Honor S, Holloway G, Ncube F, Parry J (2007) Hepatitis C virus (HCV) prevalence and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepatitis 14: 645-652.
25. Esteban J, Sauleda S, Quer J (2008) The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48: 148-162.
26. Kalilina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO (2001) Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65: 517-524.